TPV Compound, European leader in PVC compounds, has been ready for some time with new compounds compliant with Reg UE 745/2017.
Despite that following the international health emergency COVID-19, the Commission and the European Parliament have decided to postpone the deadline by one year by postponing the date to May 26, 2022, we have already approved the new solutions for the market.
Our medical PVC flexible compounds do not contain DEHP and DOTE plasticizers, because they are classified as Reprotoxic Cat. 1B and can no longer be used in medical devices.
Our medical solutions make our customers’ products safer, compliant with the standard and guarantee the same mechanical and sterilization performance as with historical products, and the same transparency in the finished product.
The new compounds are available for molding and extrusion and finds applications in all medical devices compliant with European regulation 745/2017.
Find out more about the characteristics of the new compound, get the new medical approval and solve the problem of banning old stabilizers in time.
Be ready for the new MDR regulation.
Contact our sales network or write us an email.